Company: SXTPW
Filing Date: 2025-08-27
Form Type: DEF 14A
Source: 0001213900-25-080878
Chunk: 17

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-27
Form: DEF 14A
Chunk 17
---
2. We believe that Mr. Dow is well qualified to serve as a Director given his product development experience in
tropical diseases.

Tyrone Milleris our Chief Financial
Officer. Mr. Miller joined us in 2014 and has held a number of roles since then, including Treasurer. He worked with the founder and Chief
Executive Officer of 60P and raised over $6 million in external financing. Mr. Miller also established a multinational financial reporting
system and worked with consultants in designing tax and credit strategies. He also provides key strategic advice in areas of financing
and business planning to 60P. In addition, he is the founder and Principal of Tax & Accounting Practice at Miller Tax & Advisory
since 2011. In that role, Mr. Miller advises owners of closely held businesses on accounting, financial and tax matters and has designed
accounting systems for private sector businesses. From 2002 to 2011, he was a Senior Accountant at Sachs Figurelli, LLC, where he prepared
and processed corporate and individual tax returns, consulted on reengineering accounting processes for construction, restaurant and professional
services businesses and managed staff in preparation and processing of payroll and personal property returns. Mr. Miller is currently
a Certified Public Accountant. He received a Bachelor’s of Business Administration with a concentration in International Business
from Emory University in 1996.

Kristen Landonis our Chief Commercial
Officer. Ms. Landon joined us in 2024 and brings over 26 years’ experience building and transforming pharmaceutical brands in both
start-up and large multinational companies. Ms. Landon has launched and relaunched over a dozen brands, many with peak revenues in excess
of $100 million across therapeutic categories including women’s health, infectious disease, dermatology, nephrology, and hematology/oncology.
Most recently, Ms. Landon served as Senior Vice President of Marketing and Communications at TherapeuticsMD with responsibility for the
branded portfolio, marketing insights, and corporate communications. Prior commercial leadership roles include VP Marketing at Radius
Health, VP Marketing at Sprout Pharmaceuticals (acquired by Valeant), Executive Director Women’s Health at Actavis Plc, and positions
of increasing responsibility in sales and marketing at Forest Labs, Abbott Labs, and Novartis. Ms. Landon holds an MBA from Silberman
College of Business at Fairleigh Dickinson University, and a Bachelor’s degree from Kean University.

<div align='center'>9</div>

Charles